![A. Grant Heidrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
A. Grant Heidrich
Direttore/Membro del Consiglio presso
Octave Bioscience, Inc.
Profilo
A. Grant Heidrich is currently a Director at Octave Bioscience, Inc. He was previously a Director at Millennium Pharmaceuticals, Inc., Cytokinetics, Inc., AVEO Pharmaceuticals, Inc., Tularik, Inc., National Venture Capital Association, Mayfield Fund LLC, Western Association of Venture Capitalists, and a Strategic Advisor at The Column Group LLC.
He holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Stanford University.
Posizioni attive di A. Grant Heidrich
| Società | Posizione | Inizio |
|---|---|---|
Octave Bioscience, Inc.
 Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di A. Grant Heidrich
| Società | Posizione | Fine |
|---|---|---|
Mayfield Fund LLC
 Mayfield Fund LLC Investment ManagersFinance Mayfield Fund invests in companies located in the United States. The firm focuses on AI, enterprise, consumer, semiconductor, and human & planetary health sectors. It provides financing for early and later stage capital requirements. | Direttore/Membro del Consiglio | 11/01/2011 |
| CYTOKINETICS, INCORPORATED | Direttore/Membro del Consiglio | 09/02/2011 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Direttore/Membro del Consiglio | 14/05/2008 |
| AVEO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/04/2007 |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Direttore/Membro del Consiglio | - |
Formazione di A. Grant Heidrich
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
90
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Mayfield Fund LLC
Mayfield Fund LLC Investment ManagersFinance Mayfield Fund invests in companies located in the United States. The firm focuses on AI, enterprise, consumer, semiconductor, and human & planetary health sectors. It provides financing for early and later stage capital requirements. | Finance |
National Venture Capital Association
National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Western Association of Venture Capitalists | |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Octave Bioscience, Inc.
Octave Bioscience, Inc. Medical SpecialtiesHealth Technology Develops quantitative measurement tools | Health Technology |
